Monoclonal Antibodies


More Treatment Topics

Chemotherapy | Immunotherapy | Radiotherapy | Treatment

Rituxan® is the brand marketing name of the monoclonal

Monoclonal Antibody (mAB) Therapy is a type of

At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company

Spectrum Pharmaceuticals will be presenting five study abstracts related to Zevalin, the company

Spectrum Pharmaceuticals Inc, the biotech firm that owns and makes the

Spectrum Pharmaceuticals is launching a new patient campaign surrounding the company's lead

Spectrum Pharmaceuticals has announced that it intends to acquire the international

FDA Approves the Removal of the Bioscan Requirement for ZEVALIN® Treatment

HENDERSON,

Spectrum Pharmaceuticals is reporting results from a randomized study pitting the company's

According to research presented at the annual meeting of the American Society of Hematology,

Convinced by a steady stream of research, the U.K.'s National Institute for Health and Clinical

According to a recent randomized controlled trial, rituximab increased the duration of remission

The drug Rituximab is showing to slow symptoms of lymphoma, but does it increase survival: